Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 17Colonic Neoplasms 7Rectal Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Pancreatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Unresectable Metastatic Colorectal Cancer 2Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Solid Tumors 1Prostatic Neoplasms 1Melanoma 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Gastroesophageal Adenocarcinoma 1Endometrial Neoplasms 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Solid Tumors 1Advanced Solid Tumor 1

Interventions

pembrolizumab 1folfirinox 1durvalumab 1Trastuzumab 1Single Person 1Paclitaxel 1Nivolumab 1Irinotecan 1IFL protocol 1Folfox protocol 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Gastroesophageal Adenocarcinoma × Folfox protocol × Clear all
NCT05733689 2026-03-10

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

University of California, Irvine

Phase 1 Recruiting
20 enrolled
Gastrointestinal

Gastroesophageal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡